Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
PRISM BioLab
company
About
PRISM develop therapeutic drugs that cure these intractable diseases using our unique peptide mimic technology.
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥1.40B
- Industries
- Biopharma,Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Nov 2, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
PRISM provider of a therapeutic treatment for non-oncology indications.The company develops therapeutic agents that are used to cure pulmonary fibrosis, cancer and incurable diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥1.40B
PRISM BioLab has raised a total of
¥1.40B
in funding over 2 rounds. Their latest funding was raised on
Jun 13, 2013 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 13, 2013 | Series C | ¥1.40B | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
PRISM BioLab is funded by 2 investors.
CollaboSGK
and Angel Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
CollaboSGK
|
— | Series C |
Angel Capital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
